Artiva Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Artiva Biotherapeutics Inc: Is Infosys Ltd. worth buying?
Item: Artiva Biotherapeutics Inc
Rating: 2.09108325
Author: Trendlyne DVM scores

about

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the compan...

8.93 -0.71 (-7.37%)

38.54% Fall from 52W High

434.7K

XNAS Volume

XNAS 13 Jul, 2026 4:00 PM (EDT)

Board Meeting

The next board meeting for Artiva Biotherapeutics Inc is on 22 Jul 2026 for the purpose of Artiva Biotherapeutics Inc Annual General Meeting for 2026 See details